The historical rank and industry rank for Beximco Pharmaceuticals's PB Ratio or its related term are showing as below:
BXMPY'
s PB Ratio Range Over the Past 10 Years
Min: 0.61 Med: 1.44 Max: 2.96
Current: 0.97
During the past 13 years, Beximco Pharmaceuticals's highest PB Ratio was 2.96. The lowest was 0.61. And the median was 1.44.
BXMPY's PB Ratio is not ranked
in the Drug Manufacturers industry.
Industry Median: 1.825
vs BXMPY: 0.97
During the past 12 months, Beximco Pharmaceuticals's average Book Value Per Share Growth Rate was 10.10% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 9.00% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 10.20% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Beximco Pharmaceuticals was 75.20% per year. The lowest was -35.10% per year. And the median was 9.00% per year.
Back to Basics: PB Ratio
Beximco Pharmaceuticals (OTCPK:BXMPY) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Beximco Pharmaceuticals's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beximco Pharmaceuticals PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Beximco Pharmaceuticals's PB Ratio distribution charts can be found below:
* The bar in red indicates where Beximco Pharmaceuticals's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Beximco Pharmaceuticals (BXMPY) has a PB Ratio of 0.00 as of Jun. 26, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Beximco Pharmaceuticals and its competitors. Over the past decade, Beximco Pharmaceuticals' PB Ratio has ranged from 0.61 to 2.96.
Is Beximco Pharmaceuticals' PB Ratio too high?
Beximco Pharmaceuticals' current PB Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 0.61 to a high of 2.96. Overall, Beximco Pharmaceuticals has a GF Score™ of 97/100, reflecting its overall financial health beyond just this single metric.
How does Beximco Pharmaceuticals' PB Ratio compare to ZTS and UTHR?
Beximco Pharmaceuticals' PB Ratio of 0.00 can be compared against companies in the Drug Manufacturers industry. The industry median PB Ratio is 1.83. Historically, Beximco Pharmaceuticals' own PB Ratio has ranged from 0.61 to 2.96 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.83, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Beximco Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beximco Pharmaceuticals's current PB Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beximco Pharmaceuticals stock overvalued right now?
Beximco Pharmaceuticals (BXMPY) has a current PB Ratio of 0.00. The current PB Ratio is 0.00. Beximco Pharmaceuticals' overall GF Score™ is 97/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Beximco Pharmaceuticals (BXMPY), the current PB Ratio is 0.00 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Beximco Pharmaceuticals PLC is engaged in manufacturing and marketing a wide range of generic pharmaceutical formulation products, life-saving intravenous fluids, therapeutic nutrition products, and Active Pharmaceutical Ingredients. It manufactures various pharmaceutical products including oral contraceptives, hormones, steroids, anti-histamine, anti-fibrinolytic, cardiac, musculoskeletal, respiratory, vitamin & mineral supplements, women's health products, and others. The products of the company are sold in domestic and international markets. Key revenue accrues from domestic sales.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BXMPY has been successfully added to your 